MYO9A

(redirected from MYR7)

MYO9A

A gene on chromosome 15q22-q23 that encodes a protein belonging to the myosin gene superfamily of motor proteins. MYO9A is a so-called unconventional myosin involved in intracellular movements. It regulates Rho activity in neurones and has a role in regulating neuronal morphology and function.
References in periodicals archive ?
Fitch forecasts annual capex of MYR7 billion over 2018-2019, driven primarily by these two projects.
The two class IX myosins in mammals, myosin IXa (Myo9a, myr7) and myosin IXb (Myo9b, myr 5), subsist in diverse variations among species (Newman, 2016).
IT Services Sales: MYR7.2bn in 2016 to MYR10.0bn in 2019, a CAGR of 7.7%.
* Pharmaceuticals: MYR6.60bn (USD2.10bn) in 2013 to MYR7.51bn (USD2.35bn) in 2014; +13.7% in local currency and +12.0% in US dollar terms.
Group profit before tax (PBT) for the year was 12.3 percent higher at MYR8.87bn, compared with the MYR7.90bn in 2012.
The transactions are seen to boost SME Bank's total financing assets to over MYR10bn within the next three years from MYR7.9bn at present.
Conserve has 77 employees and its 2011 revenues are expected to reach MYR7.6m (USD2.4m/EUR1.8m).Country: Malaysia, Sector: Business and Consumer ServicesTarget: Labservice (M) Sdn Bhd, Consolidated Laboratory (M) Sdn BhdBuyer: SGS SAType: Corporate acquisitionStatus: Closed
The brokerage has decreased the target price of the company to MYR6.60 from MYR7.00.
The result, which compares to a MYR109.2 million profit earned in the quarter ended March 31, 2005, beat MAS's forecast loss of MYR349 million and was boosted by a "small" MYR7 million profit in March.
Swissair is also rumoured to be interested in MAS, and observers have stated that if the deal were based on price, the Swiss carrier would probably emerge as the most favourable bidder, Swissair is believed to be offering as much as MYR7 for each MAS share.
* Pharmaceuticals: MYR6.60bn (USD2.10bn) in 2013 to MYR7.22bn (USD2.25bn) in 2014; +9.3 % in local currency and +7.6% in US dollar terms.
The two firms are estimated to generate revenues of MYR7.2m (USD2.4m/EUR1.8m) this year.Country: , MalaysiaSector: Food/Beverages/Tobacco, Business and Consumer ServicesTarget: Labservice (M) Sdn Bhd, Consolidated Laboratory (M) Sdn BhdBuyer: SGS SAType: Corporate acquisitionStatus: Closed